Laboratorios Farma | ROVI - 普通股股本

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 2.81B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	普通股股本	更改		日
Akebia Therapeutics	USD 265.42M		199K	2025-12
Alaunos Therapeutics	USD 2.38M		172K	2026-03
Almirall	EUR 214.79M		0	2025-12
Dianthus Therapeutics	USD 54.58M		11.36M	2026-03
Ionis Pharmaceuticals	USD 165.9M		3.93M	2026-03
IQVIA Holdings	USD 166.9M		2.7M	2026-03
Laboratorios Farma	EUR 51.82M		1.55M	2023-12
Moderna	USD 391M		2M	2025-09
Organon & Co	USD 262.65M		2.33M	2026-03
Pharma Mar	EUR 17.36M		0	2026-03
Revvity	USD 111.8M		1.57M	2026-03
Tectonic Therapeutic	USD 18.83M		92.19K	2026-03
Viatris	USD 1.16B		5.27M	2026-03
Xeris Pharmaceuticals	USD 172.56M		6.34M	2026-03